Dual Mechanisms of the Diazepine-Benzimidazole Derivative, DAB-19, in Modulating Glutamatergic Neurotransmission
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115299 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maxim V Nikolaev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 194223 Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Synaptic Transmission, Benzimidazoles, Glutamic Acid, Anticonvulsants. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The search for novel compounds with anticonvulsant properties remains a key focus in neuropharmacology. Recently, the diazepine-benzimidazole derivative, DAB-19, has emerged as a promising candidate due to its demonstrated anxiolytic and analgesic effects. In this study, we investigate the mechanisms underlying DAB-19’s activity, focusing on its impact on glutamatergic transmission, a key target in the pathophysiology of various central nervous system disorders. Intriguingly, while DAB-19 suppressed evoked glutamatergic transmission in rat brain slices, it simultaneously enhanced spontaneous neurotransmission. Further experiments on glutamatergic neuromuscular synapses in fly larvae revealed two distinct mechanisms: calcium-dependent potentiation of glutamate release and inhibition of spike propagation via blockade of voltage-gated sodium channels. The latter effect was directly confirmed in rat brain neurons. Given its action on sodium channels, we tested DAB-19 in the pentylenetetrazole model, where it delayed seizure onset but did not prevent seizures. These findings position DAB-19 as a multifaceted compound with significant therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 194223 Saint Petersburg, Russia.
ORCID-Profile: Oxana V Chistyakova, Tatiana Yu Postnikova, Aleksey V Zaitsev, Denis B Tikhonov
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Nikolaev, M. V., Fedorova, I. M., Chistyakova, O. V., Postnikova, T. Y., Kim, K. K., Dron, M. Y., Zaitsev, A. V., & Tikhonov, D. B. (2025). Dual Mechanisms of the Diazepine-Benzimidazole Derivative, DAB-19, in Modulating Glutamatergic Neurotransmission. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115299
Vancouver
Nikolaev MV, Fedorova IM, Chistyakova OV, Postnikova TY, Kim KK, Dron MY, et al. Dual Mechanisms of the Diazepine-Benzimidazole Derivative, DAB-19, in Modulating Glutamatergic Neurotransmission. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115299
BibTeX
@article{Nikolaev2025,
author = {Nikolaev, Maxim V and Fedorova, Irina M and Chistyakova, Oxana V and Postnikova, Tatiana Yu and Kim, Kira Kh and Dron, Mikhail Yu and Zaitsev, Aleksey V and Tikhonov, Denis B},
title = {Dual Mechanisms of the Diazepine-Benzimidazole Derivative, DAB-19, in Modulating Glutamatergic Neurotransmission},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115299}
}
EUVIMED